Skip to Main Navigation Skip to Main Content Skip to Footer
search play2 play3 facebook twitter linkedin2 cross instagram
ASCP
  • DASHBOARD
  • STORE
  • LOGOUT
  • STORE
  • LOGIN
Menu
  • Jobs
  • ASCP
  • User Auth Test Page
  • WHO Says $23B Needed To Fight COVID-19

    Bloomberg (10/28, Mulier) reports, “The World Health Organization said $23.4 billion is needed to help provide access to COVID-19 vaccines, treatments and tests in low- and middle-income countries.” The WHO “gave the estimate for the needs of its ACT-Acce...
    Full Article
  • Some People Who Are Immunocompromised May Receive Fourth COVID-19 Vaccine Dose Starting Next Year, CDC Says

    The New York Times (10/27, Slotnik) reports, “Some American adults with weakened immune systems who received a third dose of either the Pfizer-BioNTech or Moderna coronavirus vaccine authorized just for them will become eligible for a fourth shot as a boo...
    Full Article
  • AI Can Predict Horizontal Gene Transfer, Research Shows

    AI in Healthcare (10/27, Pearson) reports new research shows that horizontal gene transfer, “a prime facilitator of widespread resistance to antibiotic drugs,” is “predictable by machine learning.” This new development “could help produce better weapons i...
    Full Article
  • COVID Vaccines Are Producing Little To No Protection For Some Patients With Cancer, Study Finds

    According to HealthDay (10/27), “a new study reports that the COVID vaccines are producing little to no protection for some cancer patients.” Researchers found that “nearly 3 out of 5 blood cancer patients failed to mount an immune response against COVID...
    Full Article
  • Adhesive Surgical Drapes Linked To Decreased Risk For Postoperative Wound Contamination, Research Shows

    Infectious Disease Advisor (10/27, Nye) reports, “Results of a systematic review and meta-analysis found that adhesive drapes, with or without antimicrobial properties, were associated with a decreased risk for postoperative wound contamination.” The find...
    Full Article
  • Antidepressant Reduces Likelihood That High-Risk Patients With COVID-19 Will Be Hospitalized, Study Indicates

    The New York Times (10/27, Mueller) reports, “A large clinical trial has found that” fluvoxamine, “a common and inexpensive antidepressant, lowered the odds that high-risk” patients with “Covid-19...would be hospitalized.” The findings (10/28) were publis...
    Full Article
  • Moderna COVID-19 Vaccine Could Be Used In US Children, Teens Within Weeks, CEO Says

    Reuters (10/27, O'Donnell) reports that Moderna’s “COVID-19 vaccine could start to be used in children and teens in the United States within weeks” according to the company’s CEO. The company “plans to apply for separate U.S. regulatory clearance in child...
    Full Article
  • Scientists Stress Original COVID-19 Vaccines Are Still Working As Boosters Roll Out Across The US

    ABC News (10/27, Salzman) reports that scientists and public health experts say COVID-19 “vaccines are still holding up remarkably well for most people,” and many “now worry that the recent booster shot authorization could give the false impression that e...
    Full Article
  • Parents Remain Hesitant To Vaccinate Their Children Against COVID-19

    NBC News (10/27, Silva) reports, “As the Food and Drug Administration prepares in the coming days to authorize emergency use of the Pfizer-BioNTech vaccine for children ages 5 to 11, some parents say they don’t plan to be first in line to get their childr...
    Full Article
  • Merck Will Share License For COVID-19 Pill With Nonprofit To Facilitate Global Access

    The Washington Post (10/27, Taylor, Parker) reports, “U.S. pharmaceutical giant Merck has agreed to share its license for its experimental covid-19 drug, molnupiravir, with a nonprofit organization so that it can be manufactured widely around the world in...
    Full Article
  • FDA Panel Backs Pfizer-BioNTech COVID-19 Vaccine For Children Ages 5 To 11

    The New York Times (10/26, LaFraniere, Weiland) reports, “An independent committee of experts advising the Food and Drug Administration met on Tuesday and voted to recommend authorizing the Pfizer-BioNTech coronavirus vaccine for children 5 to 11 years ol...
    Full Article
  • Company To Begin Selling At-Home Rapid COVID-19 Test That Confirms Results Through Smartphone App

    Reuters (10/26, O'Donnell) reports Becton Dickinson and Co “has partnered with Amazon...to begin shipment of a new at-home rapid COVID-19 test that can confirm results using an entirely automated smartphone app.” The company’s “BD Veritor At-Home COVID-19...
    Full Article
  • Risk Of Neurologic Complications May Be Higher After SARS-CoV-2 Infection Than COVID-19 Vaccination, Analysis Suggests

    MedPage Today (10/26, George) reports “risk of neurologic complications was higher after SARS-CoV-2 infection than after COVID-19 vaccination” with the Oxford-AstraZeneca and Pfizer-BioNTech shots, “an analysis of 32 million people in England showed.” Fur...
    Full Article
  • Small Financial Incentives May Motivate Some To Receive COVID-19 Vaccine, Study Indicates

    HealthDay (10/26, Murez) reports offering small financial incentives can “be the difference between someone choosing to get their COVID-19 vaccine or waiting,” according to a study “that offered $25 cash cards to people who got vaccines last spring at sit...
    Full Article
  • Upcoming Influenza Season In Europe Could Be Severe For Elderly, EU Public Health Agency Warns

    Reuters (10/26, Siddarth) reports “the upcoming influenza season in Europe could be severe for the elderly and those with weak immunity,” the European Centre for Disease Prevention and Control (ECDC) “warned on Tuesday, adding that it could put a greater...
    Full Article
  • Almost Twice The Number Of People Are Getting COVID-19 Boosters Than First Shots, CDC Data Suggest

    TIME (10/26, Kluger) reports, “According to data from the US Centers for Disease Control and Prevention (CDC), [COVID-19 vaccine] booster rates are now exceeding first-shot rates across the country.” For the week ending October 24th, “just over 400,000 pe...
    Full Article
  • Moderna Agrees To Supply African Union Member Nations With Up To 110M COVID-19 Vaccine Doses

    The New York Times (10/26, Robbins, Chutel) reports, “Facing pressure for keeping its Covid vaccine out of reach of poorer countries, Moderna said on Tuesday that it had agreed to sell up to 110 million shots to African Union member nations.” In addition,...
    Full Article
  • CDC Says Salmonella Outbreak In Eight States Linked To Salami Sticks

    Healio (10/26, Downey) reports, “The CDC said an outbreak of 20 Salmonella infections in eight states was caused by eating salami sticks.” According to the agency, “the Citterio brand Premium Italian-Style Salame Sticks implicated in the outbreak are sold...
    Full Article
  • People Who Are Moderately, Severely Immunocompromised May Need Fourth mRNA COVID-19 Shot, CDC Says

    CNN (10/26, Christensen) reports on its website, “People with certain health conditions that make them moderately or severely immunocompromised may get a fourth mRNA Covid-19 shot, according to updated guidelines from the US Centers for Disease Control an...
    Full Article
  • Moderna Says Coronavirus Vaccine Works Well For Children Six To 11

    The Wall Street Journal (10/25, Loftus, Subscription Publication) reports Moderna said trial data show its COVID-19 vaccine induced strong immune responses in children from six to 11 years of age. The New York Times (10/25, Mandavilli) says the children i...
    Full Article
  • «
  • 141
  • 142
  • 143
  • 144
  • 145
  • 146
  • 147
  • 148
  • 149
  • 150
  • »
Footer
Chicago (Headquarters)
33 West Monroe Street, Suite 1600, Chicago, IL 60603

Privacy Policy 

Terms of Use

Follow Us

Copyright ©2021  by American Society for Clinical Pathology. All Rights Reserved.

Chat With BOC

close
First Name *
Last Name *
Email *
Customer ID

Request a Call from Customer Relations

Close
Name *
Topic *
Phone Number *
Scheduled Date *
Scheduled Time *
Customer Id